MRP Capital Investments’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.51M Buy
6,186
+91
+1% +$21.2K 1.32% 29
2025
Q4
$1.26M Buy
6,095
+1,820
+43% +$360K 1.06% 32
2025
Q3
$653K Sell
4,275
-115
-3% -$19.7K 0.56% 52
2025
Q2
$671K Buy
4,390
+1,490
+51% +$229K 0.46% 50
2025
Q1
$481K Buy
2,900
+1,260
+77% +$197K 0.45% 68
2024
Q4
$237K Buy
1,640
+65
+4% +$10.1K 0.22% 83
2024
Q3
$255K Sell
1,575
-285
-15% -$45.4K 0.24% 84
2024
Q2
$272K Sell
1,860
-375
-17% -$55.8K 0.25% 87
2024
Q1
$354K Buy
+2,235
New +$356K 0.35% 72
2023
Q4
Sell
-10,569
Closed -$746K 102
2023
Q3
$746K Buy
10,569
+5,556
+111% +$917K 0.82% 43
2023
Q2
$830K Buy
+5,013
New +$809K 0.81% 43
2023
Q1
Sell
-8,023
Closed -$1.42M 245
2022
Q4
$1.42M Buy
+8,023
New +$1.39M 1.57% 23

Other funds holding JNJ

MRP Capital Investments's JNJ Position: Q1 2026 in Review

MRP Capital Investments increased its Johnson & Johnson (JNJ) stake by 1.5% in Q1 2026, buying an estimated $21.2K and bringing the position to 6,186 shares worth $1.51M. The position accounts for 1.32% of the portfolio, ranked #29.

MRP Capital Investments first reported a position in JNJ in Q4 2022 and has held it in 12 quarters since. 4,618 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • MRP Capital Investments held 6,186 shares of Johnson & Johnson worth $1.51M as of Q1 2026.
  • MRP Capital Investments bought 91 Johnson & Johnson shares in Q1 2026, an estimated $21.2K.
  • Johnson & Johnson made up 1.32% of MRP Capital Investments's portfolio in Q1 2026, its #29 holding.
  • MRP Capital Investments first reported a position in Johnson & Johnson in Q4 2022 and has held it in 12 quarters since.
  • 4,618 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on MRP Capital Investments's 13F filing for Q1 2026, filed 14 May 2026.